Cardiovascular
What Lab Tests Should You Get for High Blood Pressure?
A blood pressure reading above 130/80 mmHg is the flag, but the lab work tells you why it's happening. From kidney markers to fasting glucose and aldosterone, the right panel transforms guesswork into a targeted plan — and often reveals overlapping issues like insulin resistance or metabolic syndrome hiding beneath the surface.

What Lab Tests Should You Get for High Blood Pressure?
High blood pressure affects nearly half of American adults, yet most people receive only a cuff measurement and a prescription without ever understanding the underlying drivers (CDC, 2023). Blood pressure elevation rarely has a single cause — it can stem from kidney dysfunction, hormonal imbalances, chronic inflammation, electrolyte dysregulation, or insulin resistance. Running the right lab panel is what separates reactive treatment from root-cause resolution.
This guide walks through every meaningful lab test used to evaluate hypertension, explains the mechanistic connections to related conditions like metabolic syndrome and chronic fatigue, and outlines how targeted supplementation — personalized to your actual results — can support healthy blood pressure levels.
---
The Core Lab Panel for High Blood Pressure
Before any lifestyle or supplement intervention, these are the baseline tests your clinician should order:
Comprehensive Metabolic Panel (CMP)
The CMP covers kidney function markers (creatinine, BUN, eGFR), liver enzymes, electrolytes (sodium, potassium, chloride, bicarbonate), and blood glucose. Each of these intersects with blood pressure regulation:
- eGFR and creatinine: The kidneys regulate blood volume and pressure through the renin-angiotensin-aldosterone system (RAAS). Chronic kidney disease is both a cause and a consequence of hypertension.
- Potassium: Low serum potassium raises blood pressure by increasing sodium retention. A 2013 meta-analysis in the British Medical Journal found that increased potassium intake significantly reduced systolic blood pressure by an average of 3.49 mmHg in hypertensive adults (Aburto et al., BMJ 2013; PMID: 23558164).
- Fasting glucose: Hyperglycemia damages the vascular endothelium and promotes arterial stiffness, directly elevating BP.
Lipid Panel
Dyslipidemia and hypertension frequently co-occur. Elevated LDL-C, low HDL-C, and high triglycerides are each independently linked to endothelial dysfunction. If your clinician ordered a standard lipid panel, it's worth asking whether advanced markers like ApoB or LDL particle number are appropriate — see our guide on how long it takes to lower LDL particle number for context on timeline expectations.
Urinalysis with Microalbuminuria
Protein in the urine (microalbuminuria) is an early sign of hypertensive kidney damage. It also predicts future cardiovascular events. This is one of the most underordered tests in routine hypertension workups.
Complete Blood Count (CBC)
Anemia reduces blood oxygen delivery, triggering compensatory mechanisms that increase heart rate and cardiac output — both of which raise blood pressure. A CBC rules this in or out quickly.
Thyroid Panel (TSH, Free T3, Free T4)
Both hypothyroidism and hyperthyroidism alter blood pressure. Hypothyroidism tends to raise diastolic pressure through increased vascular resistance; hyperthyroidism raises systolic through elevated cardiac output. TSH alone is insufficient — free T3 and free T4 complete the picture.
Aldosterone-to-Renin Ratio (ARR)
Primary hyperaldosteronism is the most common secondary (correctable) cause of hypertension, present in 5–10% of hypertensive patients. Without testing, it is routinely missed and mismanaged with antihypertensives that don't address the root cause (Funder et al., Journal of Clinical Endocrinology & Metabolism 2016; PMID: 26934393).
Magnesium (RBC Magnesium)
Serum magnesium is a poor reflection of total body magnesium stores. RBC magnesium is more accurate and clinically meaningful. A 2012 meta-analysis in the European Journal of Clinical Nutrition found that magnesium supplementation produced a statistically significant reduction in both systolic and diastolic blood pressure, particularly in individuals with low baseline magnesium (Kass et al., EJCN 2012; PMID: 22318649).
---
Lab Tests for High Blood Sugar and Its Role in Hypertension
Insulin resistance and hypertension are deeply intertwined. Elevated insulin promotes sodium retention through the kidneys, activates the sympathetic nervous system, and stimulates smooth muscle cell proliferation in arterial walls — all of which raise blood pressure.
The key lab tests for high blood sugar in a hypertension context include:
| Test | Why It Matters for BP |
|---|---|
| Fasting glucose | Direct vascular damage above 100 mg/dL |
| Hemoglobin A1c (HbA1c) | Reflects 3-month average glycemic exposure |
| Fasting insulin | Most sensitive marker of early insulin resistance |
| HOMA-IR | Calculated insulin resistance index (fasting glucose × fasting insulin ÷ 405) |
| C-peptide | Differentiates insulin resistance from beta-cell failure |
You can read more about what A1C reflects mechanistically in our article what does A1C actually measure — understanding the timeline helps set realistic expectations for dietary interventions.
Omega-3 fatty acids (EPA/DHA) have demonstrated meaningful reductions in both blood pressure and markers of insulin resistance. A 2020 Cochrane-style analysis published in the Journal of the American Heart Association found that omega-3 supplementation at doses above 2g/day reduced systolic blood pressure by approximately 2 mmHg in adults with elevated cardiovascular risk (Miller et al., JAHA 2014; PMID: 24780044).
---
Lab Tests for Metabolic Syndrome
Metabolic syndrome is diagnosed when three or more of the following are present: elevated waist circumference, high triglycerides, low HDL-C, elevated fasting glucose, and blood pressure ≥130/85 mmHg. Because hypertension is one of its five criteria, patients presenting with high blood pressure should always be screened for the full metabolic syndrome cluster.
The lab work needed to evaluate metabolic syndrome overlaps significantly with the hypertension panel:
- Triglycerides: Elevated triglycerides ≥150 mg/dL are both a metabolic risk marker and a surrogate for elevated VLDL particles, which contribute to arterial plaque. See why triglycerides stay high despite treatment for a deeper breakdown of bioavailability and dietary interactions.
- HDL-C: Low HDL-C (below 40 mg/dL in men, 50 mg/dL in women) reflects impaired reverse cholesterol transport.
- hsCRP: High-sensitivity C-reactive protein identifies systemic low-grade inflammation, a driver of both metabolic syndrome and hypertension. hsCRP above 3.0 mg/L significantly increases cardiovascular risk.
- Uric acid: Hyperuricemia activates the RAAS, reduces nitric oxide bioavailability, and is an independent predictor of hypertension. It is rarely tested but mechanistically important (Feig et al., NEJM 2008; PMID: 18650515).
If your results show two or more of these markers out of range alongside elevated BP, you are not dealing with isolated hypertension — you are dealing with a systemic metabolic phenotype that requires a broader intervention strategy. Addressing only blood pressure in isolation is an incomplete clinical response.
---
Lab Tests for Erectile Dysfunction: The Overlooked Hypertension Connection
Erectile dysfunction (ED) and hypertension share a common root: endothelial dysfunction. The penile arteries are among the smallest end-organ vessels and often show impaired nitric oxide signaling before larger vessels are visibly affected. This makes ED a cardiovascular warning sign in men, sometimes appearing years before a cardiac event.
Lab tests relevant to both ED and hypertension include:
- Total and free testosterone: Low testosterone is associated with increased cardiovascular risk, visceral adiposity, and higher blood pressure.
- Sex hormone-binding globulin (SHBG): High SHBG lowers free testosterone; relevant to both libido and cardiovascular metabolism.
- Estradiol: Estrogen balance in men affects vascular tone and is influenced by body fat.
- LH and FSH: Help differentiate primary (testicular) from secondary (pituitary) hypogonadism.
- PSA: Clinically standard for men over 40 before any hormone-related workup.
- Full lipid panel + hsCRP: Endothelial risk shared across both conditions.
The mechanistic overlap is well-documented. A 2012 review in the European Heart Journal confirmed that men with ED have a significantly elevated 10-year MACE (major adverse cardiac event) risk independent of traditional cardiovascular risk factors (Vlachopoulos et al., EHJ 2012; PMID: 23111337).
If you're managing blood pressure and also experiencing ED, insist on the full panel above rather than siloed testing. These are not separate problems.
---
Lab Tests for Chronic Fatigue in the Hypertension Context
Chronic fatigue is one of the most underappreciated symptoms in hypertensive patients. It may reflect:
- Adrenal dysregulation: Chronically elevated cortisol raises blood pressure via mineralocorticoid receptors. Morning salivary cortisol and a 4-point diurnal cortisol test reveal HPA axis function that blood tests can miss.
- Sleep apnea correlation: Not a blood test, but overnight pulse oximetry or a formal sleep study is clinically warranted in hypertensive patients with fatigue, as untreated apnea directly elevates nocturnal blood pressure.
- Iron and ferritin: Low ferritin impairs mitochondrial energy production and promotes fatigue. It is commonly deficient in menstruating women but also in men with poor dietary iron absorption.
- Vitamin D (25-OH): Deficiency is associated with both fatigue and elevated blood pressure through RAAS activation. The NIH Office of Dietary Supplements recognizes vitamin D status as a factor in cardiovascular regulation.
- B12 and folate: Deficiency drives hyperhomocysteinemia, which damages endothelial cells and raises cardiovascular risk while simultaneously contributing to neurological fatigue.
If you are experiencing fatigue alongside high blood pressure and haven't had a full thyroid panel, adrenal workup, ferritin, vitamin D, B12, and homocysteine checked, your lab workup is incomplete. These findings frequently co-exist with hypertension, and treating only the BP number without addressing the fatigue drivers produces suboptimal outcomes.
---
What This Means for Your Formula
Lab findings in hypertension are rarely isolated — they point to a network of interconnected physiological stressors. The supplement strategy should match that network.
Here are three Ones ingredients that are directly relevant to the lab patterns described above:
Omega-3 (EPA/DHA): Clinical trials consistently show blood pressure-lowering effects at doses above 2g/day of combined EPA+DHA. Ones sources a clinically dosed omega-3 that aligns with the 2–4g daily range showing measurable impact on both triglycerides and vascular tone. This is particularly relevant if your triglycerides are elevated alongside blood pressure — a common metabolic syndrome cluster.
Magnesium Glycinate (via Magnesium Complex): Ones includes a Magnesium Complex system blend that prioritizes highly bioavailable forms. Magnesium acts as a natural calcium channel blocker in vascular smooth muscle, promoting vasodilation. Individuals with low RBC magnesium and elevated blood pressure may see clinically meaningful BP reductions with consistent magnesium repletion, as supported by the Kass 2012 meta-analysis cited above.
Vitamin D3 + K2 (MK-7): If your 25-OH vitamin D comes back below 30 ng/mL alongside elevated BP, this pairing is mechanistically sound. Vitamin D modulates RAAS activity, while K2 ensures calcium is directed to bone rather than arterial walls. Ones pairs D3 with MK-7 form of K2 to support both vascular and skeletal outcomes simultaneously.
If your Ones AI analysis surfaces a pattern matching metabolic syndrome — high triglycerides, insulin resistance markers, elevated hsCRP, and blood pressure — the formula may also include the Heart Support system blend, which is calibrated for broader cardiovascular risk rather than a single biomarker.
For context on how cholesterol and blood pressure interventions interact, the article on supplements that affect cholesterol ratio provides a useful overlap view.
---
Key Takeaways
- High blood pressure is a symptom, not a complete diagnosis — lab work reveals whether the driver is renal, hormonal, metabolic, or inflammatory.
- A thorough hypertension panel includes CMP, lipid panel, RBC magnesium, aldosterone-to-renin ratio, thyroid function, microalbuminuria, and hsCRP at minimum.
- Insulin resistance and metabolic syndrome share overlapping lab markers with hypertension — fasting insulin and HOMA-IR are underutilized but highly informative.
- In men, erectile dysfunction is an endothelial warning sign that warrants a combined BP and hormonal workup.
- Chronic fatigue alongside high BP should trigger testing for adrenal function, vitamin D, ferritin, B12, and homocysteine — these are not separate problems.
- Targeted supplementation — omega-3 EPA/DHA, magnesium, vitamin D3+K2 — has robust clinical evidence for blood pressure support when matched to the relevant lab pattern, not taken generically.
---
This article is for educational purposes only. Always consult a licensed healthcare provider before making changes to your supplement or medication regimen.